These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6391735)

  • 21. Impact of sublingual immunotherapy on seasonal asthma and skin reactivity in children allergic to Parietaria pollen treated with inhaled fluticasone propionate.
    Pajno GB; Vita D; Parmiani S; Caminiti L; La Grutta S; Barberio G
    Clin Exp Allergy; 2003 Dec; 33(12):1641-7. PubMed ID: 14656349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical efficacy of microencapsulated timothy grass pollen extract in grass-allergic individuals.
    TePas EC; Hoyte EG; McIntire JJ; Umetsu DT
    Ann Allergy Asthma Immunol; 2004 Jan; 92(1):25-31. PubMed ID: 14756461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term comparison of sublingual immunotherapy vs inhaled budesonide in patients with mild persistent asthma due to grass pollen.
    Marogna M; Spadolini I; Massolo A; Berra D; Zanon P; Chiodini E; Canonica GW; Passalacqua G
    Ann Allergy Asthma Immunol; 2009 Jan; 102(1):69-75. PubMed ID: 19205289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of high-doses sublingual immunotherapy in ultra-rush scheme in children allergic to grass pollen.
    Stelmach I; Kaczmarek-Woźniak J; Majak P; Olszowiec-Chlebna M; Jerzynska J
    Clin Exp Allergy; 2009 Mar; 39(3):401-8. PubMed ID: 19134016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety of sublingual immunotherapy started during the pollen season.
    Ariano R; Incorvaia C; La Grutta S; Marcucci F; Pajno G; Sensi L; Di Cara G; Sieber J; Yacoub MR; Frati F
    Curr Med Res Opin; 2009 Jan; 25(1):103-7. PubMed ID: 19210143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen.
    Rolinck-Werninghaus C; Wolf H; Liebke C; Baars JC; Lange J; Kopp MV; Hammermann J; Leupold W; Bartels P; Gruebl A; Bauer CP; Schnitker J; Wahn U; Niggemann B
    Allergy; 2004 Dec; 59(12):1285-93. PubMed ID: 15507097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen-induced rhinoconjunctivitis.
    Didier A; Worm M; Horak F; Sussman G; de Beaumont O; Le Gall M; Melac M; Malling HJ
    J Allergy Clin Immunol; 2011 Sep; 128(3):559-66. PubMed ID: 21802126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized, controlled study of specific immunotherapy in monosensitized subjects with seasonal rhinitis: effect on bronchial hyperresponsiveness, sputum inflammatory markers and development of asthma symptoms.
    Crimi N; Li Gotti F; Mangano G; Paolino G; Mastruzzo C; Vancheri C; Lisitano N; Polosa R
    Ann Ital Med Int; 2004; 19(2):98-108. PubMed ID: 15317270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyposensitization in ragweed pollinosis.
    Speer F; Carrasco LC
    Ann Allergy; 1976 Dec; 37(6):391-7. PubMed ID: 999058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Local nasal immunotherapy with extract in powder form is effective and safe in grass pollen rhinitis: a double-blind study.
    Andri L; Senna G; Betteli C; Givanni S; Andri G; Dimitri G; Falagiani P; Mezzelani P
    J Allergy Clin Immunol; 1996 Jan; 97(1 Pt 1):34-41. PubMed ID: 8568135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Double-blind, placebo-controlled evaluation of grass pollen specific immunotherapy with oral drops administered sublingually or supralingually.
    Panzner P; Petrás M; Sýkora T; Lesná I
    Respir Med; 2008 Sep; 102(9):1296-304. PubMed ID: 18585908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of AIT in children including potential to prevent the development of asthma.
    Valovirta E
    Allergy; 2011 Jul; 66 Suppl 95():53-4. PubMed ID: 21668856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs.
    Varney VA; Gaga M; Frew AJ; Aber VR; Kay AB; Durham SR
    BMJ; 1991 Feb; 302(6771):265-9. PubMed ID: 1998791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The treatment of seasonal hay fever and asthma in children. A controlled trial of pre-seasonal depot pollen therapy.
    Sanders S
    Practitioner; 1966 Jun; 196(176):811-5. PubMed ID: 5936067
    [No Abstract]   [Full Text] [Related]  

  • 35. Double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization.
    Vourdas D; Syrigou E; Potamianou P; Carat F; Batard T; André C; Papageorgiou PS
    Allergy; 1998 Jul; 53(7):662-72. PubMed ID: 9700035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Long term follow up after parenteral specific hyposensitization in children (author's transl)].
    Urbanek R; Karitzky D
    Klin Padiatr; 1975 Nov; 187(6):513-7. PubMed ID: 1240550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Depigmented-polymerized mixed grass/birch pollen extract immunotherapy is effective in polysensitized patients.
    Pfaar O; Biedermann T; Klimek L; Sager A; Robinson DS
    Allergy; 2013 Oct; 68(10):1306-13. PubMed ID: 23991896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of hay fever with sodium cromoglycate, hyposensitization, or a combination.
    Andersen NH; Jeppesen F; Schiøler T; Osterballe O
    Allergy; 1987 Jul; 42(5):343-51. PubMed ID: 3115130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy.
    Bufe A; Eberle P; Franke-Beckmann E; Funck J; Kimmig M; Klimek L; Knecht R; Stephan V; Tholstrup B; Weisshaar C; Kaiser F
    J Allergy Clin Immunol; 2009 Jan; 123(1):167-173.e7. PubMed ID: 19130937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 300IR 5-Grass pollen sublingual tablet offers relief from nasal symptoms in patients with allergic rhinitis.
    Serrano E; Wahn HU; Didier A; Bachert C
    Am J Rhinol Allergy; 2014; 28(6):471-6. PubMed ID: 25335122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.